Evidence map›Paper›PMID 37185197›Full record

ArticleBMJ open2023

Efficacy of continuous intravenous remimazolam versus midazolam in the extraction of impacted wisdom teeth: protocol of a randomised controlled trial.

Lejunzi Wang, Quan Jing, Lijian Pei, Mohan Li, Xia Ruan, Shaohui Chen, Yuelun Zhang, Kuo Wan, Yuguang Huang

Registry-linked trialOpen access · goldAbstract readClinical Trial Protocol
In one paragraph

Article in BMJ open, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05350085 (A Randomized Controlled Clinical Trial of Remimazolam Benzenesulfonate Usage in the Extraction of Impacted Wisdom Teeth), which is not on this map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05350085 naunknown statusnot on this map

A Randomized Controlled Clinical Trial of Remimazolam Benzenesulfonate Usage in the Extraction of Impacted Wisdom Teeth

TypeinterventionalSponsorPeking Union Medical College HospitalRan2022 to 2023Enrolled150ConditionsDental Anxiety, Sedation Complication, Anterograde AmnesiaArmsRemimazolam besylate, Midazolam
3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. The median effective dose (EDBMC anesthesiology · 2026
    Article
  5. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 2 countries.

Lejunzi WangDepartment of Anesthesiology, Peking Union Medical College Hosptial, Beijing, People's Republic of China.ORCID 0000-0002-4303-3270
Quan JingDepartment of Stomatology, Peking Union Medical College Hospital, Beijing, People's Republic of China.
Lijian Pei *Department of Anesthesiology, Peking Union Medical College Hosptial, Beijing, People's Republic of China hazelbeijing@vip.163.com wankuo@126.com.ORCID 0000-0001-7174-9105
Mohan LiDepartment of Anesthesiology, Peking Union Medical College Hosptial, Beijing, People's Republic of China.
Xia RuanDepartment of Anesthesiology, Peking Union Medical College Hosptial, Beijing, People's Republic of China.
Shaohui ChenDepartment of Anesthesiology, Peking Union Medical College Hosptial, Beijing, People's Republic of China.
Yuelun ZhangMedical Research Center, Peking Union Medical College Hospital, Beijing, People's Republic of China.ORCID 0000-0001-7990-9003
Kuo Wan *Department of Stomatology, Peking Union Medical College Hospital, Beijing, People's Republic of China hazelbeijing@vip.163.com wankuo@126.com.
Yuguang HuangDepartment of Anesthesiology, Peking Union Medical College Hosptial, Beijing, People's Republic of China.
Chinese Academy of Medical Sciences & Peking Union Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionBenzodiazepines such as midazolam are widely used to moderately sedate patients during impacted wisdom tooth extraction to reduce anxiety in outpatient surgery. This present protocol was designed to determine whether continuous intravenous remimazolam, a new ultrashort-acting benzodiazepine, produces superior postoperative recovery quality to that of midazolam in patients undergoing extraction of impacted wisdom teeth. METHODS AND ANALYSIS: This study is a multicentre randomised controlled trial conducted at Peking Union Medical College Hospital, Beijing Anzhen Hospital and Beijing Shijitan Hospital in China. Approximately 150 participants undergoing extraction of impacted mandibular wisdom teeth will be randomly allocated to two groups (remimazolam and midazolam). The participants will be administered standard interventions to ensure they achieve a sedation level of III on the Ramsay sedation scale during the treatment. Preoperative and anaesthesia management and surgical techniques will be standardised for all participants. The primary outcome is recovery time for complete alertness and the secondary outcomes are anterograde amnesia during and after surgery, and interruption during operation for poor compliance or safety concerns. ETHICS AND DISSEMINATION: This study has been approved by the Ethics Review Committee of Peking Union Medical College Hospital (approval number: ZS-3142), Beijing Anzhen Hospital (approval number: KS2022082) and Beijing Shijitan Hospital (approval number: 2023-4). TRIAL REGISTRATION NUMBER: NCT05350085.

Indexed as

MidazolamTooth, ImpactedBenzodiazepinesHumansMolar, ThirdMulticenter Studies as TopicRandomized Controlled Trials as TopicBenzodiazepinesMidazolamremimazolamAdult anaesthesiaAnxiety disordersOral & maxillofacial surgery

Identifiers

PMID37185197
PMCPMC10151835
OpenAlexW4366983372

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.